|
Age (years)
|
61.5 ± 13.7
|
63.5 ± 11.5
|
0.7813
|
|
Men
|
5 (62.5 %)
|
3 (50.0 %)
|
0.1477
|
|
Body surface area (m2)
|
1.64 ± 0.11
|
1.60 ± 0.10
|
0.5998
|
|
NYHA class III or IV (n, %)
|
4 (50 %)
|
1 (16.7 %)
|
0.1977
|
|
Preoperative laboratory examinations
|
|
Hb (g/dL)
|
10.9 ± 1.8
|
10.4 ± 1.1
|
0.5397
|
|
Na (mEq/L)
|
139.1 ± 4.0
|
136.0 ± 3.6
|
0.1567
|
|
Cre (mg/dL)
|
1.20 ± 0.54
|
1.02 ± 0.28
|
0.478
|
|
T-Bil (mg/dL)
|
1.4 ± 0.6
|
1.02 ± 0.2
|
0.408
|
|
TP (g/dL)
|
6.2 ± 0.5
|
6.3 ± 0.2
|
0.792
|
|
Alb (g/dL)
|
3.5 ± 0.3
|
3.5 ± 0.2
|
0.831
|
|
eGFR (ml/min./1.73 m2)
|
47.6 ± 26.6
|
52.9 ± 14.4
|
0.668
|
|
CKD stage 3b or worse (n, %)
|
4 (50 %)
|
2 (33.3 %)
|
0.533
|
|
Preoperative echocardiography
|
|
LVEDD (mm)
|
56.8 ± 19.8
|
50.3 ± 9.4
|
0.371
|
|
LVEF (%)
|
43.1 ± 14.0
|
52.0 ± 6.7
|
0.180
|
|
TAPSE (mm)
|
16.0 ± 5.0
|
20.3 ± 3.1
|
0.086
|
|
RVFAC (%)
|
33.5 ± 7.1
|
38.3 ± 6.5
|
0.214
|
|
Euroscore
|
12.6 ± 8.1
|
8.0 ± 4.0
|
0.2486
|
|
Japan Score
|
15.9 ± 11.8
|
10.1 ± 5.1
|
0.2820
|
|
Type of surgery (p value based on CABG alone vs. others)
| | |
0.0499
|
|
CABG alone
|
0 (0 %)
|
2 (33.3 %)
| |
|
Valvular surgery alone
|
5 (62.5 %)
|
3 (50.0 %)
| |
|
CABG + Valvular surgery
|
1 (12.5 %)
|
1 (16.7 %)
| |
|
Pericardiectomy
|
1 (12.5 %)
|
0 (16.7 %)
| |
|
Pulmonary thrombectomy
|
1 (12.5 %)
|
0 (16.7 %)
| |
